Morning Overview on MSN
The ETH Zurich team behind the new Alzheimer’s compound is hunting a drugmaker to carry it forward
Researchers at ETH Zurich have identified a compound that targets a previously overlooked protein aggregation mechanism in ...
Morning Overview on MSN
A new vitamin K-based compound just helped the brain regrow lost neurons in the lab — engineered straight at Alzheimer’s and Parkinson’s
Most drugs aimed at Alzheimer’s and Parkinson’s disease try to slow the damage. A small team at Japan’s Shibaura Institute of ...
Researchers created Compound 10 to block GRK2 enzyme aggregation and protect mitochondria in Alzheimer's disease.
In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Silvio Di Castro, Senior Technology Scientist at AstraZeneca, about his research, as well as the role of compound ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results